BackZelira Therapeutics Limited Overview

Zelira Therapeutics Limited Inventory

Zelira Therapeutics Limited's inventory is $480K.

Get informed when a big investor buys or sells

+ Follow
Inventory
$477913.00
↓ 61.84% YoYΔ $-774398.00 vs prior year quarter

Peer trimmed avg / median

Loading

Zelira Therapeutics Limited Inventory History

Loading

Zelira Therapeutics Limited vs. peers: Inventory Comparison

Loading

Zelira Therapeutics Limited Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Zelira Therapeutics Limited (ZLD.AX) FAQ

Zelira Therapeutics Limited (ZLD.AX) currently reports a inventory of $480K as of June 2025. That compares with $1.3M in the prior-year period — down 61.8% year over year. Use the charts on this page to explore Zelira Therapeutics Limited's inventory history and peer comparisons.

Zelira Therapeutics Limited's inventory decreased from $1.3M to $480K — a 61.8% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zelira Therapeutics Limited reported $480K in inventory as of June 2025. That compares with $1.3M in the prior-year period — down 61.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $480K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zelira Therapeutics Limited, and consider following ZLD.AX for alerts when major investors trade the stock.

Zelira Therapeutics Limited is classified in the Healthcare sector. On inventory, it currently shows $480K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZLD.AX with unrelated industries.

Questions & Answers